HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B E Johnson Selected Research

B E Johnson Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 03/2000
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 07/2000
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2014 - 07/2000
3Lung Neoplasms (Lung Cancer)
12/2001 - 10/2000
1COVID-19
01/2022
1Infections
01/2022
1Stomatitis
02/2014
1Adenocarcinoma
11/2001
1Carcinoma (Carcinomatosis)
11/2001
1Dyspnea (Shortness of Breath)
01/2001
1Disease Progression
07/2000
1Brain Neoplasms (Brain Tumor)
07/2000

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
02/2014 - 07/2000
2EverolimusFDA Link
02/2014 - 02/2014
2Paclitaxel (Taxol)FDA LinkGeneric
12/2001 - 07/2000
2DNA (Deoxyribonucleic Acid)IBA
09/2000 - 03/2000
1ErbB Receptors (EGF Receptor)IBA
10/2014
1vandetanib (ZD6474)IBA
10/2014
1Docetaxel (Taxotere)FDA Link
10/2014
1Proteins (Proteins, Gene)FDA Link
10/2014
1Biomarkers (Surrogate Marker)IBA
10/2014
1TOR Serine-Threonine KinasesIBA
02/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2014
1Etoposide (VP 16)FDA LinkGeneric
02/2014
1tipifarnib (R115777)IBA
08/2004
1TransferasesIBA
08/2004
1OligonucleotidesIBA
11/2001
1Messenger RNA (mRNA)IBA
11/2001
1Oxygen (Dioxygen)IBA
01/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2000
1Genetic Markers (Genetic Marker)IBA
09/2000
1Tyrosine Kinase InhibitorsIBA
07/2000
1Stem Cell FactorIBA
07/2000
1Imatinib Mesylate (Gleevec)FDA Link
07/2000
1Phosphotransferases (Kinase)IBA
07/2000

Therapy/Procedure

7Therapeutics
01/2022 - 07/2000
3Drug Therapy (Chemotherapy)
02/2001 - 10/2000
1Cranial Irradiation
07/2000